Blood conservation: Preoperative, perioperative, and postoperative blood management options

Brian P. Chalmers; Matthew P. Abdel

doi:10.1053/j.sart.2018.02.008

Blood conservation: Preoperative, perioperative, and postoperative blood management options

Brian P. Chalmers, Matthew P. Abdel

Orthopedic Surgery

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Perioperative blood loss during elective total joint arthroplasty (TJA) can be significant, traditionally resulting in high blood transfusion rates. However, due to the risks and costs of allogeneic blood transfusion, the focus in contemporary TJA has been on strategies to minimize perioperative blood loss. While a multimodal approach is paramount in elective TJA, three main factors have contributed dramatically to the reduced allogeneic blood transfusion rates: (1) preoperative assessment and treatment of anemia, (2) expanded use of antifibrinolytics, particularly tranexamic acid (TXA), and (3) a restrictive transfusion strategy postoperatively.

Original language	English (US)
Pages (from-to)	259-263
Number of pages	5
Journal	Seminars in arthroplasty
Volume	28
Issue number	4
DOIs	https://doi.org/10.1053/j.sart.2018.02.008
State	Published - Dec 2017

Keywords

Blood conservation
Total hip arthroplasty (THA)
Total joint arthroplasty (TJA)
Total knee arthroplasty (TKA)
Tranexamic acid (TXA)

ASJC Scopus subject areas

Surgery
Orthopedics and Sports Medicine

Access to Document

10.1053/j.sart.2018.02.008

Fingerprint Dive into the research topics of 'Blood conservation: Preoperative, perioperative, and postoperative blood management options'. Together they form a unique fingerprint.

Cite this

@article{7bb22b595c6c47c1b52ec653fb247079,

title = "Blood conservation: Preoperative, perioperative, and postoperative blood management options",

abstract = "Perioperative blood loss during elective total joint arthroplasty (TJA) can be significant, traditionally resulting in high blood transfusion rates. However, due to the risks and costs of allogeneic blood transfusion, the focus in contemporary TJA has been on strategies to minimize perioperative blood loss. While a multimodal approach is paramount in elective TJA, three main factors have contributed dramatically to the reduced allogeneic blood transfusion rates: (1) preoperative assessment and treatment of anemia, (2) expanded use of antifibrinolytics, particularly tranexamic acid (TXA), and (3) a restrictive transfusion strategy postoperatively.",

keywords = "Blood conservation, Total hip arthroplasty (THA), Total joint arthroplasty (TJA), Total knee arthroplasty (TKA), Tranexamic acid (TXA)",

author = "Chalmers, {Brian P.} and Abdel, {Matthew P.}",

year = "2017",

month = dec,

doi = "10.1053/j.sart.2018.02.008",

language = "English (US)",

volume = "28",

pages = "259--263",

journal = "Seminars in Arthroplasty",

issn = "1045-4527",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Blood conservation

T2 - Preoperative, perioperative, and postoperative blood management options

AU - Chalmers, Brian P.

AU - Abdel, Matthew P.

PY - 2017/12

Y1 - 2017/12

N2 - Perioperative blood loss during elective total joint arthroplasty (TJA) can be significant, traditionally resulting in high blood transfusion rates. However, due to the risks and costs of allogeneic blood transfusion, the focus in contemporary TJA has been on strategies to minimize perioperative blood loss. While a multimodal approach is paramount in elective TJA, three main factors have contributed dramatically to the reduced allogeneic blood transfusion rates: (1) preoperative assessment and treatment of anemia, (2) expanded use of antifibrinolytics, particularly tranexamic acid (TXA), and (3) a restrictive transfusion strategy postoperatively.

AB - Perioperative blood loss during elective total joint arthroplasty (TJA) can be significant, traditionally resulting in high blood transfusion rates. However, due to the risks and costs of allogeneic blood transfusion, the focus in contemporary TJA has been on strategies to minimize perioperative blood loss. While a multimodal approach is paramount in elective TJA, three main factors have contributed dramatically to the reduced allogeneic blood transfusion rates: (1) preoperative assessment and treatment of anemia, (2) expanded use of antifibrinolytics, particularly tranexamic acid (TXA), and (3) a restrictive transfusion strategy postoperatively.

KW - Blood conservation

KW - Total hip arthroplasty (THA)

KW - Total joint arthroplasty (TJA)

KW - Total knee arthroplasty (TKA)

KW - Tranexamic acid (TXA)

UR - http://www.scopus.com/inward/record.url?scp=85043244335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043244335&partnerID=8YFLogxK

U2 - 10.1053/j.sart.2018.02.008

DO - 10.1053/j.sart.2018.02.008

M3 - Article

AN - SCOPUS:85043244335

VL - 28

SP - 259

EP - 263

JO - Seminars in Arthroplasty

JF - Seminars in Arthroplasty

SN - 1045-4527

IS - 4

ER -